Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.

Abstract:

:Stathmin is a p53-regulated protein known to influence microtubule dynamics. Because several chemotherapeutic agents used to treat breast cancer alter the dynamic equilibrium of tubulin polymerization, stathmin may play an important role in determining the sensitivity to these drugs. Therefore, we evaluated the effect of stathmin expression on the action of taxanes and Vinca alkaloids using a panel of human breast cancer cell lines. Cell lines harboring mutant p53 expressed high levels of stathmin. Two cell lines with different levels of endogenous stathmin expression and isogenic-paired cell lines transfected to overexpress stathmin were used to determine whether or not stathmin modulated the sensitivity to drugs. Overexpression of stathmin decreased polymerization of microtubules, markedly decreased binding of paclitaxel, and increased binding of vinblastine. Stathmin overexpression decreased sensitivity to paclitaxel and, to a lesser extent, to vinblastine. In contrast, stathmin content had no significant effect on the sensitivity to chemotherapeutic drugs that do not target microtubules. Cell lines overexpressing stathmin were more likely to enter G(2) but less likely to enter mitosis as determined by fluorescence-activated cell sorting and mitotic index. This effect was magnified when stathmin-overexpressing cells were treated with vinblastine as measured by the detection of proteins phosphorylated in early mitosis. These data suggest that the action of antimicrotubule drugs can be affected by stathmin in at least two ways: (a) altered drug binding; and (b) growth arrest at the G(2) to M boundary. Mutant p53 breast cancers exhibiting high levels of stathmin may be resistant to antimicrotubule agents.

journal_name

Cancer Res

journal_title

Cancer research

authors

Alli E,Bash-Babula J,Yang JM,Hait WN

subject

Has Abstract

pub_date

2002-12-01 00:00:00

pages

6864-9

issue

23

eissn

0008-5472

issn

1538-7445

journal_volume

62

pub_type

杂志文章
  • Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth.

    abstract::Membrane type-1 matrix metalloproteinase (MT1-MMP) is a promising drug target in malignancy. The structure of MT1-MMP includes the hemopexin domain (PEX) that is distinct from and additional to the catalytic domain. Current MMP inhibitors target the conserved active site in the catalytic domain and, as a result, repre...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-4149

    authors: Remacle AG,Golubkov VS,Shiryaev SA,Dahl R,Stebbins JL,Chernov AV,Cheltsov AV,Pellecchia M,Strongin AY

    更新日期:2012-05-01 00:00:00

  • Novel gene sequences expressed by human melanoma cells identified by molecular subtraction.

    abstract::Despite the variety of approaches used, only a limited number of tumor-associated antigens have been described for each histological type of tumor. In this report, we present a new strategy involving molecular subtraction to identify novel melanoma-associated gene sequences. Toward this end, 156 complementary DNA clon...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hutchins JT,Deans RJ,Mitchell MS,Uchiyama C,Kan-Mitchell J

    更新日期:1991-03-01 00:00:00

  • Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.

    abstract::Vaccination with irradiated tumor cells genetically modified to secrete granulocyte-macrophage colony-stimulating factor (GM-CSF tumor vaccine) induces a potent systemic antitumor immunity. To develop a protocol for cancer therapy to further augment the host immune response, we examined the effects of the GM-CSF tumor...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wakimoto H,Abe J,Tsunoda R,Aoyagi M,Hirakawa K,Hamada H

    更新日期:1996-04-15 00:00:00

  • CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.

    abstract::CXCL10 was recently shown to exert antimalignancy functions by influencing the tumor microenvironment. Here, we have taken a different approach, investigating the effects of CXCL10 directly on tumor-promoting functions in colorectal carcinoma (CRC) cells. CXCL10 expression was detected in preferred metastatic sites of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3087

    authors: Zipin-Roitman A,Meshel T,Sagi-Assif O,Shalmon B,Avivi C,Pfeffer RM,Witz IP,Ben-Baruch A

    更新日期:2007-04-01 00:00:00

  • Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.

    abstract::Tn and sialylated Tn (sTn) are blood group-related epitopes expressed on mucins of colon carcinoma and other epithelial tumors and are, therefore, potential targets for immunological control. We have immunized 20 colorectal cancer patients at high risk for recurrence with a vaccine consisting of partially desialylated...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: O'Boyle KP,Zamore R,Adluri S,Cohen A,Kemeny N,Welt S,Lloyd KO,Oettgen HF,Old LJ,Livingston PO

    更新日期:1992-10-15 00:00:00

  • Comparison of mutagenicity and induction of sister chromatid exchange in Chinese hamster cells exposed to hematoporphyrin derivative photoradiation, ionizing radiation, or ultraviolet radiation.

    abstract::Cell culture studies have been performed to compare the mutagenic potential and the induction of sister chromatid exchanges for hematoporphyrin derivative photoradiation, ionizing radiation, and UV radiation. The mutation frequency in Chinese hamster ovary cells at the hypoxanthine-guanine phosphoribosyltransferase lo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gomer CJ,Rucker N,Banerjee A,Benedict WF

    更新日期:1983-06-01 00:00:00

  • Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction.

    abstract::Our laboratory has found genomic imprinting of a large genomic domain of human 11p15.5, identifying six imprinted genes within this domain: (a) insulin-like growth factor II (IGF-II), an important autocrine growth factor in a wide variety of malignancies; (b) H19, an untranslated RNA that is a putative growth suppress...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Feinberg AP

    更新日期:1999-04-01 00:00:00

  • Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.

    abstract::We examined whether herpes simplex virus thymidine kinase (HSV-TK) gene expression driven by the promoter of the vascular endothelial growth factor (VEGF) gene that is activated by hypoxia is effective in killing highly metastatic Lewis lung carcinoma A11 cells under hypoxic conditions. We isolated the promoter region...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Koshikawa N,Takenaga K,Tagawa M,Sakiyama S

    更新日期:2000-06-01 00:00:00

  • Plasminogen Activator Inhibitor-1 in Cancer: Rationale and Insight for Future Therapeutic Testing.

    abstract::Despite its function as an inhibitor of urokinase and tissue-type plasminogen activator (PA), PA inhibitor-1 (PAI-1) has a paradoxical protumorigenic role in cancer, promoting angiogenesis and tumor cell survival. In this review, we summarize preclinical evidence in support of the protumorigenic function of PAI-1 that...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-15-0876

    authors: Placencio VR,DeClerck YA

    更新日期:2015-08-01 00:00:00

  • Biochemical and ultrastructural characterization of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone).

    abstract::Stable variants of the human cell line, VA2-B, have been developed which are 10- to 20-fold less sensitive to the antiproliferative effects of methylglyoxal bis(guanylhydrazone) (MGBG) than the parent cell lines and which are not drug transport deficient. The lines were characterized biochemically giving particular at...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kramer DL,Zychlinski L,Wiseman A,Porter CW

    更新日期:1983-12-01 00:00:00

  • Exploiting DNA Replication Stress for Cancer Treatment.

    abstract::Complete and accurate DNA replication is fundamental to cellular proliferation and genome stability. Obstacles that delay, prevent, or terminate DNA replication cause the phenomena termed DNA replication stress. Cancer cells exhibit chronic replication stress due to the loss of proteins that protect or repair stressed...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-18-3631

    authors: Ubhi T,Brown GW

    更新日期:2019-04-15 00:00:00

  • Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness.

    abstract::Cyclins and cyclin-dependent kinases regulate the cell cycle. Cyclin A has a dual role in cell proliferation. It is essential in the S phase for DNA replication, and it is also involved in G2-M-phase transition, signifying actively dividing cells. The expression of cyclin A was determined by immunohistochemistry in pa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huuhtanen RL,Blomqvist CP,Böhling TO,Wiklund TA,Tukiainen EJ,Virolainen M,Tribukait B,Andersson LC

    更新日期:1999-06-15 00:00:00

  • A gonadotropin-releasing hormone-II antagonist induces autophagy of prostate cancer cells.

    abstract::Gonadotropin-releasing hormone-I (GnRH-I) is known to directly regulate prostate cancer cell proliferation. However, the role of GnRH-II in prostate cancer is unclear. Here, we investigated the effect of the GnRH-II antagonist trptorelix-1 (Trp-1) on growth of PC3 prostate cancer cells. Trp-1 induced growth inhibition...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-2115

    authors: Kim DK,Yang JS,Maiti K,Hwang JI,Kim K,Seen D,Ahn Y,Lee C,Kang BC,Kwon HB,Cheon J,Seong JY

    更新日期:2009-02-01 00:00:00

  • Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats.

    abstract::The lymphatic absorption and tissue distribution of free [14C]Adriamycin, "empty" [3H]liposomes, free [14C]Adriamycin plus empty [3H]liposomes, and [14C]Adriamycin entrapped into [3H]liposomes have been examined at intervals after i.p. injection into rats. Following treatment with empty [3H]liposomes, almost 30% of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Parker RJ,Hartman KD,Sieber SM

    更新日期:1981-04-01 00:00:00

  • Vimentin filaments support extension of tubulin-based microtentacles in detached breast tumor cells.

    abstract::Solid tumor metastasis often involves detachment of epithelial carcinoma cells into the vasculature or lymphatics. However, most studies of cytoskeletal rearrangement in solid tumors focus on attached cells. In this study, we report for the first time that human breast tumor cells produce unique tubulin-based protrusi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-6589

    authors: Whipple RA,Balzer EM,Cho EH,Matrone MA,Yoon JR,Martin SS

    更新日期:2008-07-15 00:00:00

  • Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor.

    abstract::Vigorous activity after diagnosis was recently reported to be inversely associated with prostate cancer-specific mortality. However, men with metastatic disease may decrease their activity due to their disease; thus, a causal interpretation is uncertain. We therefore prospectively examined vigorous activity and brisk ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-3932

    authors: Richman EL,Kenfield SA,Stampfer MJ,Paciorek A,Carroll PR,Chan JM

    更新日期:2011-06-01 00:00:00

  • Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen.

    abstract::Protection of spermatogenesis from cytotoxic drug-induced damage has been investigated in the rat. Complete germinal aplasia was observed at 8 and 11 weeks after four doses of procarbazine hydrochloride administered weekly (150 mg/kg, first dose; 100 mg/kg, 3 subsequent doses). Pretreatment of rats for 6 weeks plus co...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Delic JI,Bush C,Peckham MJ

    更新日期:1986-04-01 00:00:00

  • Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane).

    abstract::Certain bis(2,6-dioxopiperazine) derivatives, which include ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl]propane; ADR-529) and its racemic compound ICRF 159 (Razoxane), have been investigated as antineoplastic agents. In addition, ICRF-187 is currently under intense study as an agent to ameliorate the cardiac toxic...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Gorbsky GJ

    更新日期:1994-02-15 00:00:00

  • Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor.

    abstract::We previously reported that both sodium butyrate and trichostatin A (TSA), both of which are known as inhibitors of histone deacetylase, arrest human tumor cells at G1 and G2-M and activate the cyclin-dependent kinase inhibitor, the p21/WAF1/Cip1 gene promoter, through the Sp1 sites. In this study, we identified Sp1 a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Sowa Y,Orita T,Minamikawa-Hiranabe S,Mizuno T,Nomura H,Sakai T

    更新日期:1999-09-01 00:00:00

  • Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.

    abstract::The p75 and p110 isoforms of the CUX1 homeodomain protein are overexpressed in breast tumors and cancer cell lines. To assess and compare the ability of these short CUX1 isoforms in driving mammary tumor development, we used site-specific transgenesis into the Hprt locus to generate transgenic mice expressing p75 or p...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4899

    authors: Cadieux C,Kedinger V,Yao L,Vadnais C,Drossos M,Paquet M,Nepveu A

    更新日期:2009-09-15 00:00:00

  • Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia.

    abstract::Whereas transcriptional silencing of genes due to epigenetic mechanisms is one of the most important alterations in acute lymphoblastic leukemia (ALL), some recent studies indicate that DNA methylation contributes to down-regulation of miRNAs during tumorigenesis. To explore the epigenetic alterations of miRNAs in ALL...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-4025

    authors: Agirre X,Vilas-Zornoza A,Jiménez-Velasco A,Martin-Subero JI,Cordeu L,Gárate L,San José-Eneriz E,Abizanda G,Rodríguez-Otero P,Fortes P,Rifón J,Bandrés E,Calasanz MJ,Martín V,Heiniger A,Torres A,Siebert R,Román-Gomez J,

    更新日期:2009-05-15 00:00:00

  • Immunotherapy of murine hepatic metastases with lymphokine-activated killer cells expanded in serum-free media and recombinant interleukin 2.

    abstract::It has been shown that the systemic administration of lymphokine-activated killer (LAK) cells with recombinant interleukin 2 (RIL-2) is effective in reducing the number of established pulmonary and hepatic metastases in murine models. Similarly, this modality of therapy has been proven effective against certain select...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lafreniere R,Borkenhagen K,Bryant LD,Huchcroft S

    更新日期:1989-05-01 00:00:00

  • Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer.

    abstract::Excess production of the proinflammatory IL6 has both local and systemic tumor-promoting activity in many cancers, including ovarian cancer. However, treatment of advanced ovarian cancer patients with a neutralizing IL6 antibody yielded little efficacy in a previous phase II clinical trial. Here, we report results tha...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-1801

    authors: Milagre CS,Gopinathan G,Everitt G,Thompson RG,Kulbe H,Zhong H,Hollingsworth RE,Grose R,Bowtell DD,Hochhauser D,Balkwill FR

    更新日期:2015-04-01 00:00:00

  • Progesterone-binding cyst protein in human breast tumor cytosol.

    abstract::Breast tumor cytosol has been analyzed for the presence of a progesterone-binding protein (PBCP), commonly present in benign breast cysts in huge concentrations. In 377 primary carcinoma investigated PBCP was present in measurable quantities in 60.7% using "rocket" immunoelectrophoresis. Concentrations of PBCP ranged ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lea OA,Kvinnsland S,Thorsen T

    更新日期:1987-12-01 00:00:00

  • Influence of genotype and the organ of origin on the subtype of T-cell in Moloney lymphomas induced by transfer of preleukemic cells from athymic and thymus-bearing mice.

    abstract::Thymus, spleen, and bone marrow of 1-month-old neonatally Moloney murine leukemia virus-inoculated mice have been transferred to 400-R-irradiated syngeneic recipients of the opposite sex. The donor or recipient origin of T-cell lymphomas arising in the host animal was identified by the sex chromosome marker. Spleen an...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Asjö B,Skoog L,Palminger I,Wiener F,Isaak D,Cerny J,Fenyö EM

    更新日期:1985-03-01 00:00:00

  • Oncogenic role of miR-483-3p at the IGF2/483 locus.

    abstract::hsa-mir-483 is located within intron 2 of the IGF2 locus. We found that the mature microRNA (miRNA) miR-483-3p is overexpressed in 100% of Wilms' tumors. In addition, colon, breast, and liver cancers exhibit high or even extremely high levels of miR-483-3p in approximately 30% of the cases. A coregulation with IGF2 mR...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-4456

    authors: Veronese A,Lupini L,Consiglio J,Visone R,Ferracin M,Fornari F,Zanesi N,Alder H,D'Elia G,Gramantieri L,Bolondi L,Lanza G,Querzoli P,Angioni A,Croce CM,Negrini M

    更新日期:2010-04-15 00:00:00

  • Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44.

    abstract::The molecular pathways driving mesenchymal glioblastoma (GBM) are still not well understood. We report here that truncated glioma-associated oncogene homolog 1 (tGLI1) is a tumor-specific transcription factor that facilitates GBM growth, is enriched in the mesenchymal subtype of GBM and glioma stem cells (GSC), and pr...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-2933

    authors: Rimkus TK,Carpenter RL,Sirkisoon S,Zhu D,Pasche BC,Chan MD,Lesser GJ,Tatter SB,Watabe K,Debinski W,Lo HW

    更新日期:2018-05-15 00:00:00

  • Differences in glycosylation state of fibronectin from two rat colon carcinoma cell lines in relation to tumoral progressiveness.

    abstract::We have investigated the biosynthesis and carbohydrate structure of fibronectin secreted by two rat colon carcinoma cell lines. The cell line Prob yields progressive tumors after s.c. injection in syngeneic BD IX rats while tumors developed by Regb cells disappear after 20 days. No difference was observed in the fibro...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kasbaoui L,Harb J,Bernard S,Meflah K

    更新日期:1989-10-01 00:00:00

  • A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.

    abstract::Emerging evidence supporting the activation of the Akt-mammalian target of rapamycin (mTOR) signaling network in head and neck squamous cell carcinoma (HNSCC) progression has provided the rationale for exploring the therapeutic potential of inhibiting this pathway for HNSCC treatment. Indeed, rapamycin, a clinically r...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-1756

    authors: Amornphimoltham P,Patel V,Leelahavanichkul K,Abraham RT,Gutkind JS

    更新日期:2008-02-15 00:00:00

  • Allele separation facilitates interpretation of potential splicing alterations and genomic rearrangements.

    abstract::Mutations that alter normal splice patterns and genomic rearrangements are common causes of hereditary diseases including hereditary nonpolyposis colorectal cancer. However, abnormal transcripts can be difficult to detect and interpret because splicing patterns are often heterogeneous even in normal cells. Standard te...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nakagawa H,Yan H,Lockman J,Hampel H,Kinzler KW,Vogelstein B,De La Chapelle A

    更新日期:2002-08-15 00:00:00